Why Oxford's positive COVID vaccine results are puzzling scientists.

  title={Why Oxford's positive COVID vaccine results are puzzling scientists.},
  author={Ewen Callaway},
COVID‐19: vaccine’s progress
Under the pressure of the COVID‐19 pandemic, vaccines were developed and rolled out into mass vaccination campaigns at incredible speed, documenting astonishing high levels of protection against disease.
COVID‐19 vaccines: one step towards the beginning of the end of the global impact of the pandemic
An overview of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccine development and its context is provided.
COVID-19 Vaccines: Current Conditions and Future Prospects
An overview of the current SARS-CoV-2 vaccines with their mechanisms of action, current technologies utilized in manufacturing of the vaccines, and limitations in this new field with emerging data is provided.
New Generation Vaccines for COVID-19 Based on Peptide, Viral Vector, Artificial Antigen Presenting Cell, DNA or mRNA
An overview of multiple vaccines that have been manufactured from December 2020 up to April 2021 is provided and also offers a perspective on their efficacy, safety, advantages, and limitations.
A Net Benefit Approach for the Optimal Allocation of a COVID-19 Vaccine
It is shown that optimal vaccine allocation will depend on the public health policies, and human behaviours in place at the time of allocation, and the outcomes of vaccine allocation policies can be greatly supported with interventions targeting contact reduction in critical sub-populations.
Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected millions of people and caused tremendous morbidity and mortality worldwide. Effective treatment for
Tackling the COVID-19 Pandemic- A Review
An extensive knowledge on transmission mechanisms, clinical spectrums, specific diagnostics methods, host-virus interactions are required to tackle this pandemic.
Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence
In the absence of any clinically proven treatment options, the current clinical management of COVID-19 includes symptom management, infection prevention and control measures, optimized supportive care, and intensive care support in severe or critical illness.
Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review
While drugs that target SARS-CoV-2 entry or replication are expected to confer the greatest benefits at the early stage of the infection, anti-inflammatory drugs would be more effective in limiting the inflammatory processes that drive the worsening of the disease.